Mesenchymal stem cells: current clinical progress in ARDS and COVID-19

Stem Cell Research & Therapy
Kun XiaoLixin Xie

Abstract

Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate. Survivors usually have low quality of life. Current clinical management strategies are respiratory support and restricted fluid input, and there is no suggested pharmacological treatment. Mesenchymal stromal cells (MSCs) have been reported to be promising treatments for lung diseases. MSCs have been shown to have a number of protective effects in some animal models of ARDS by releasing soluble, biologically active factors. In this review, we will focus on clinical progress in the use of MSCs as a cell therapy for ARDS, which may have clinical implications during the coronavirus disease 2019 (COVID-19) pandemic.

References

Apr 2, 1999·Science·M F PittengerD R Marshak
May 14, 2005·American Journal of Respiratory Cell and Molecular Biology·Mauricio RojasKenneth L Brigham
Sep 24, 2005·American Journal of Respiratory and Critical Care Medicine·Roberto LoiDaniel J Weiss
Feb 16, 2008·Circulation Research·Michael T GanterJean-François Pittet
Apr 11, 2014·American Journal of Respiratory and Critical Care Medicine·Murali ShyamsundarCecilia M O'Kane
Jun 21, 2014·Clinical and Translational Medicine·Heather MainMichael D O'Connor
Dec 4, 2014·The Lancet. Respiratory Medicine·James WalterMichael A Matthay
Dec 23, 2014·The Lancet. Respiratory Medicine·Jennifer G WilsonMichael A Matthay
Aug 20, 2015·Stem Cells Translational Medicine·Oscar E SimonsonKatarina Le Blanc
Aug 10, 2017·The New England Journal of Medicine·B Taylor ThompsonKathleen D Liu
Oct 12, 2017·The Journal of Trauma and Acute Care Surgery·Ben AntebiLeopoldo C Cancio
Jun 27, 2018·Proceedings of the National Academy of Sciences of the United States of America·Laura HakanpaaPipsa Saharinen
Mar 16, 2019·Nature Reviews. Disease Primers·Michael A MatthayCarolyn S Calfee
Mar 31, 2019·The Lancet. Respiratory Medicine·Haibo ZhangArthur S Slutsky
May 24, 2019·IScience·Mujib UllahAvnesh S Thakor
Dec 18, 2019·Stem Cell Research & Therapy·Jibin HanYuanyuan Li
Jan 11, 2020·Stem Cell Research & Therapy·Khawaja Husnain Haider, Beatrice Aramini
Jan 23, 2020·Cellular and Molecular Life Sciences : CMLS·Xing-Liang FanQing-Ling Fu
Mar 21, 2020·Lancet·Puja MehtaUNKNOWN HLH Across Speciality Collaboration, UK
Apr 9, 2020·The European Respiratory Journal·Maroun KhouryDaniel J Weiss
Apr 25, 2020·Nature Medicine·Waradon SungnakUNKNOWN HCA Lung Biological Network
May 2, 2020·Drug Development Research·Rodolfo Pedro RothlinFacundo Germán Pelorosso
May 6, 2020·Stem Cell Research & Therapy·Shan LiuLin Zou

❮ Previous
Next ❯

Citations

Sep 22, 2020·Curēus·Rishita PujariAyna Serwat
Oct 10, 2020·Human Cell·Hugo C RodriguezAshim Gupta
Jan 5, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Nikoo Hossein-KhannazerMassoud Vosough
Nov 23, 2020·International Immunopharmacology·Mohadeseh Haji AbdolvahabLeila Farahmand
Nov 16, 2020·International Immunopharmacology·Arun KumarVishal Aggarwal
Jan 21, 2021·Stem Cell Research & Therapy·Haggai KaspiRevital Aricha
Feb 3, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Saniya MahendirattaBikash Medhi
Dec 18, 2020·Frontiers in Cell and Developmental Biology·André CoelhoAna Colette Maurício
Mar 3, 2021·Stem Cell Research & Therapy·Rodrigo N RiedelJulieta L Maymó
Mar 16, 2021·Journal, Genetic Engineering & Biotechnology·Reham A El-ShahatEntsar A Saad
Apr 23, 2021·Expert Opinion on Biological Therapy·Ashim GuptaNicola Maffulli
May 14, 2021·Stem Cell Research & Therapy·Birbal SinghMohammad Ali Moni
May 15, 2021·Regenerative Medicine·Gaia SpinettiPaolo Madeddu
Jun 18, 2021·Chronic Diseases and Translational Medicine·Kun Xiao, Li-Xin Xie
Jul 2, 2021·Frontiers in Cell and Developmental Biology·Babak ArjmandBagher Larijani
Jul 3, 2021·Microorganisms·Sonia LaneriRaffaela Pero
Aug 8, 2021·Reviews in Medical Virology·Maryam Yousefi DehbidiMohammad Doroudian
Aug 23, 2021·Stem Cell Research & Therapy·Mai AbdelgawadAhmed Lotfy
Sep 22, 2021·Cell Biochemistry and Function·Mohsen EbrahimiSadra Samavarchi Tehrani

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Clinical Trials Mentioned

NCT01902082
NCT01849237
NCT01775774
NCT02097641

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.